Spikevax is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Moderna Us, Inc.. The primary component is Elasomeran.
Product ID | 80777-100_8483facf-1d72-4de3-ac81-eedc517bac1b |
NDC | 80777-100 |
Product Type | Vaccine |
Proprietary Name | Spikevax |
Generic Name | Covid-19 Vaccine, Mrna |
Dosage Form | Injection, Suspension |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2022-04-01 |
Marketing Category | BLA / |
Application Number | BLA125752 |
Labeler Name | Moderna US, Inc. |
Substance Name | ELASOMERAN |
Active Ingredient Strength | 0 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-04-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
61434-043 | SPIKEVAX | COVID-19 Vaccine, mRNA |
80777-100 | Spikevax | COVID-19 Vaccine, mRNA |
0069-2025 | Comirnaty | COVID-19 Vaccine, mRNA |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SPIKEVAX 97037862 not registered Live/Pending |
ModernaTx, Inc. 2021-09-21 |
SPIKEVAX 90247367 not registered Live/Pending |
ModernaTx, Inc. 2020-10-11 |